Products regulated by the Food and Drug Administration comprise 25% of American consumer spending. The approaches used to approve these products can be as varied and complex as the products themselves. Such differences are dictated by Federal law and FDA identifies and enforces the relative risks and benefits that the products pose to consumers. These results convey summaries of products approved by FDA, including information about their past history and present status. The information not only applies to New Molecular Entities, but includes FDA approval information pertaining to new ingredients, dosages, therapeutic uses and generic equivalents.
Top 5 by number of approval applications
Top 5 Generic Drug Active Ingredients
NoneTop 5 Innovator Sponsors
Vericel Corporation (2) Gilead Sciences (2) Novartis (1) Fibrocell Technologies, Inc. (1) Bristol-Myers Squibb (1)Top 5 Generics Sponsors
NoneNote: these approvals are sourced from Drugs@FDA and Purple Book, and do not currently reflect older FDA approvals and/or other evidence of US marketing.
api_id | earliest_approval | earliest_innovator | sponsor_org_id | Active Ingredient | Innovator Sponsor | Approval Years | Innovator Years | Innovator Approvals | Generics Approvals | Drug Type |
---|
org_id | earliest_approval | earliest_innovator | Sponsor | Approval Years | Innovator Years | Innovator Approvals | Generics Approvals | Org Type |
---|
org_id | source_sponsor_name | ApplNo | Type | Approval | Sponsor | Active Ingredients | Marketing Status | Class | Priority Review? | FDA |
---|